These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1805551)

  • 21. [Multifocal axonal motor neuropathy associated with anti-ganglioside antibodies].
    Matsui M; Kaji R; Oka N; Nishio T; Kimura J
    Rinsho Shinkeigaku; 1992 Oct; 32(10):1130-5. PubMed ID: 1297559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.
    Kuijf ML; van Doorn PA; Tio-Gillen AP; Geleijns K; Ang CW; Hooijkaas H; Hop WC; Jacobs BC
    J Neurol Sci; 2005 Dec; 239(1):37-44. PubMed ID: 16154154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do GM1 antibodies induce demyelination?
    Lange DJ; Trojaborg W
    Muscle Nerve; 1994 Jan; 17(1):105-7. PubMed ID: 8264688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-GM1 gangliosides antibodies in multifocal motor neuropathies].
    Younes-Chennoufi AB; Baumann N
    Rev Neurol (Paris); 1996 May; 152(5):375-9. PubMed ID: 8881433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower motor neuron syndrome associated with anti-GM1 antibodies.
    Villa A; Molina H; Sanz OP; Garreto N; Kholer G; Sica RE
    Medicina (B Aires); 1997; 57(3):270-4. PubMed ID: 9640758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous gamma-globulin inhibits binding of anti-GM1 to its target antigen.
    Malik U; Oleksowicz L; Latov N; Cardo LJ
    Ann Neurol; 1996 Jan; 39(1):136-9. PubMed ID: 8572660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
    Yuki N; Yoshino H; Sato S; Ohno T; Miyatake T
    Rinsho Shinkeigaku; 1990 Sep; 30(9):989-93. PubMed ID: 2265511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.
    Nobile-Orazio E; Manfredini E; Carpo M; Meucci N; Monaco S; Ferrari S; Bonetti B; Cavaletti G; Gemignani F; Durelli L
    Ann Neurol; 1994 Sep; 36(3):416-24. PubMed ID: 8080249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations].
    Alpa M; Ferrero B; Cavallo R; Naretto C; Gennaro M; Bellizia L; Sena LM; Roccatello D
    G Ital Nefrol; 2002; 19(6):617-21. PubMed ID: 12508165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical and diagnostic role of anti-GM1 antibody testing.
    Kornberg AJ; Pestronk A
    Muscle Nerve; 1994 Jan; 17(1):100-4. PubMed ID: 8264687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy.
    Bech E; Andersen H; Orntoft TF; Jakobsen J
    Ann Neurol; 1998 Jan; 43(1):72-8. PubMed ID: 9450770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
    Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
    Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lower motor neuron disease and signs of dysimmunity].
    Azulay JP; Attarian S; Boucraut J; Pouget J
    Rev Neurol (Paris); 2000 Apr; 156(4):372-9. PubMed ID: 10795014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.
    Pestronk A; Chaudhry V; Feldman EL; Griffin JW; Cornblath DR; Denys EH; Glasberg M; Kuncl RW; Olney RK; Yee WC
    Ann Neurol; 1990 Mar; 27(3):316-26. PubMed ID: 2327739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The sensitivity and specificity of anti-GM1 antibody testing.
    Taylor BV; Gross L; Windebank AJ
    Neurology; 1996 Oct; 47(4):951-5. PubMed ID: 8857725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1.
    Zielasek J; Ritter G; Magi S; Hartung HP; Toyka KV
    J Neurol; 1994 Jul; 241(8):475-80. PubMed ID: 7964915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.
    Pestronk A; Choksi R; Blume G; Lopate G
    Neurology; 1997 Apr; 48(4):1104-6. PubMed ID: 9109910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spectrum of neurologic disease associated with anti-GM1 antibodies.
    Sadiq SA; Thomas FP; Kilidireas K; Protopsaltis S; Hays AP; Lee KW; Romas SN; Kumar N; van den Berg L; Santoro M
    Neurology; 1990 Jul; 40(7):1067-72. PubMed ID: 2162499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.